Shi Yin Foo
Chief Tech/Sci/R&D Officer at Cardioxyl Pharmaceuticals LLC
Network origin in Shi Yin Foo first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Cardioxyl Pharmaceuticals LLC
 Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Thryv Therapeutics, Inc.
 Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada.
9
| Holding Company | Medical/Nursing Services | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Shi Yin Foo via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Founder Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
HyperBranch Medical Technology, Inc.
 HyperBranch Medical Technology, Inc. Medical SpecialtiesHealth Technology HyperBranch Medical Technology, Inc. develops and markets biosurgical devices. It develops and markets products primarily for the traumatic or surgically induced wound market. The firm offers Adherus AutoSpray Dural Sealant which is a synthetic, absorbable, two-component dural sealant indicated for use in patients as an adjunct to standard methods of dural repair. The company was founded by Mark W. Grinstaff and Anthony J. Sherbondy in March 2003 and is headquartered in Durham, NC. | Medical Specialties | Director/Board Member Director/Board Member | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Neotropix, Inc.
 Neotropix, Inc. BiotechnologyHealth Technology Neotropix, Inc. develops virus-based therapies for cancer treatment. It has developed NTX-010 virus, a small cell lung cancer treatment and as a treatment of pediatric cancers, such as neuroblastoma. The company was founded by Paul L. Hallenbeck in 2003 and is headquartered in Malvern, PA. | Biotechnology | Director/Board Member Director/Board Member | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Director/Board Member | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ECHO GLOBAL LOGISTICS, INC. | Trucking | Corporate Officer/Principal | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member | |
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chairman | |
| Boston College | College/University | Undergraduate Degree | |
| University of Tennessee | College/University | Doctorate Degree | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Santa Clara University | College/University | Masters Business Admin | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SUPERNUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member | |
| GLYCOMIMETICS, INC. | Pharmaceuticals: Major | Chairman | |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Director/Board Member | |
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member | |
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member | |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The Warren Alpert Medical School | College/University | Doctorate Degree | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
| EDGEWISE THERAPEUTICS, INC. | Biotechnology | Founder | |
Angel Pharmaceuticals Co., Ltd.
 Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
| ARS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of California, Berkeley | College/University | Graduate Degree | |
| Vanderbilt University | College/University | Doctorate Degree |
Statistics
International
| United States | 48 |
| Canada | 3 |
| China | 2 |
Sectoral
| Health Technology | 36 |
| Consumer Services | 9 |
| Finance | 3 |
| Commercial Services | 3 |
| Transportation | 2 |
Operational
| Director/Board Member | 131 |
| Corporate Officer/Principal | 53 |
| Independent Dir/Board Member | 36 |
| Chairman | 26 |
| Founder | 23 |
Most connected contacts
| Insiders | |
|---|---|
| Michael Barrett | 49 |
| Peter Thompson | 39 |
| Jean-François Pariseau | 24 |
| Robert Booth | 23 |
| Jeff Bank Clark | 20 |
| Paul Truex | 17 |
| Chris Kroeger | 15 |
| Robert J. Garland | 12 |
| Debra A. Odink | 9 |
| Douglas Cowart | 8 |
| Kimberly McCutcheon Jablonski | 8 |
| Philip T. Sager | 8 |
| Melissa Koomey | 8 |
| Gary L. Stiles | 7 |
| Ronald Borchardt | 6 |
- Stock Market
- Insiders
- Shi Yin Foo
- Company connections
